Introduction
Parents of preschool children are often concerned about behavior problems and wonder whether these issues are normal or early signs of attention deficit hyperactivity disorder (ADHD). Practitioners need to be able to identify and distinguish between normal behavior for this age group and clinical markers for disorder. They also must balance the benefits of early identification and intervention with the consequences of over-diagnosis and the possible prescription of medication when not truly indicated.
ADHD, a neurodevelopmental disorder characterized by inattentiveness and/or hyperactivity/impulsiveness (HA/I), is one of the primary reasons that children are referred to mental health specialists [1] . Although diagnoses are rarely made before 7 years of age, ADHD symptoms often occur as early as the preschool years (ages 3-5 years). As most of the research conducted on ADHD focuses on school-age children, much remains to be learned about the manifestation of symptoms, effectiveness of various treatments, and long-term outcomes for preschool-age children presenting with symptoms [2] .
This review includes an updated discussion of the prevalence and cause of the disorder in preschool children as well as an examination of the limitations of diagnosis and currently recommended interventions. As the inattentive subtype of ADHD occurs in fewer than 1/1000 preschoolers in the general population [3] , this review article will limit its focus to the hyperactive/impulsive and combined subtypes of ADHD.
Prevalence
Although the majority of children from 2 to 6 years of age are reported to have at least some symptoms of ADHD, most do not meet full diagnostic criteria for the disorder [4] . The current estimated prevalence of ADHD among preschool-age children is 2-6%, a percentage slightly lower than the estimated 3-7% rate for school-age children reported in 1996 [5, 6] and considerably lower than more recent estimates of the prevalence of ADHD in school-age children. According to data from the National Children's Health Survey, the reported prevalence of the disorder in children aged 4-17 years has actually increased substantially, with a 21.8% increase (7.8-9 .5%) in parent-reported diagnoses made in the 4-year interval from 2003 to 2007 [7] . In 2007, 1.6% of preschool children (ages [3] [4] [5] were identified as having ADHD (2.2% boys; 0.9% girls); in 2003, when a similar question was asked, 1.3% of preschool children (ages 3-5) were identified as having ADHD (2.0% boys; 0.6% girls). Of course, there is some debate as to whether the reported change is due to an actual increased incidence of the disorder, or is rather attributable to an increased cultural acceptance of the disorder and/or changes in access to care [7] .
Whereas ADHD is almost three times as likely to be diagnosed in boys than in girls in school-age children, the sex differences are less pronounced with preschoolage children -with twice as many boys being diagnosed as girls [8 ] . As previously noted, very few preschool-age children are diagnosed with the inattentive subtype. A study using the Preschool Age Psychiatric Assessment (PAPA), an interviewer-based psychiatric diagnostic measure, found that approximately 55 of 1073 (5.1%) preschoolers from a pediatric clinic met ADHD criteria. Of the identified children, 57% met criteria for the hyperactive/impulsive subtype, 41% the combined type, and only 2% the inattentive type [3] . This distribution of ADHD subtype for preschool children is markedly different from what is seen in school-age youngsters. In children 6 and above, the hyperactive/impulsive subtype is extremely rare. Whereas ADHD subtype was previously thought to be stable on a patient-specific basis, more recent longitudinal studies have shown that many older children with the inattentive form of ADHD originally met criteria for the combined subtype.
Cause
Despite extensive research on the cause of ADHDincluding genetic and environmental factors -the exact causes remain unclear. It is most often a combination of multiple risk factors that interact, together contributing to the disorder.
Genetics and neurobiology
Twin studies of 3-year-olds have demonstrated that about 70% of the cause of ADHD can be explained by genetic factors. Similar heritability rates have been reported at 7, 10, and 12 years of age [9] . Both the DRD4 and DAT genes have been implicated in ADHD because of their involvement in dopamine regulation. It is suspected that children with ADHD have deficits in dopamine regulation, contributing to symptoms of executive dysfunction, inattention, impulsivity, and hyperactivity. DRD4 has been shown to be related to attention, motivation, and exploratory behavior in various studies. A recent study conducted by Martel et al. [10 ] found a specific DRD4 tandem repeat polymorphism to moderate the effects of inconsistent parenting and marital conflict in leading to ADHD in school-age children. This finding is a perfect example of the gene-environment interaction, whereby this DRD4 polymorphism may increase a child's responsiveness to environmental factors.
A preliminary neuroimaging study of preschool children with ADHD has revealed impairment in subcortical brain regions, specifically reduced volumes of caudate nuclei in the basal ganglia. As with most of the research on ADHD, the neuroimaging research has focused mainly on school-age children, who appear to exhibit impairment in cortical regions. In contrast, the findings of this study on younger children indicate that subcortical brain regions, specifically basal ganglia, may provide answers to the early cause of ADHD [11 ] .
Acquired risk
Multiple studies have explored particular environmental risk factors that could contribute to the development of ADHD. Pregnancy and other birth-related factors, such as toxemia, lengthy labor, low birth weight, cocaine and alcohol exposure, and prematurity have been implicated in the disorder [12, 13] . A child's exposure to environmental lead, iron deficiency, and/or sleep-disordered breathing have also been suggested as related factors [14] [15] [16] . There are a variety of childhood disorders that have been associated with ADHD, including viral and bacterial infections of the central nervous system [13] .
Yet, of all factors that appear to be related, maternal smoking has received the greatest attention. Recently, multiple studies have examined the effect of parental smoking both prenatally and postnatally and later development of ADHD in their offspring. Nomura et al.
[17 ] examined prenatal exposure to maternal and paternal smoking and found that paternal smoking prenatally was not associated with an increased risk of the child developing the disorder, but maternal smoking was. This Diagnosis and management of preschool ADHD Kaplan and Adesman 685
Key points
Marked differences between preschool and schoolage children with attention deficit hyperactivity disorder (ADHD) exist. ADHD can be reliably diagnosed in preschool children using DSM-IV criteria. Parent training in behavior management techniques is the first-line treatment approach for children aged 3-5 years. Treatment with stimulant medication can be used in children with moderate-to-severe ADHD, primarily in cases where behavior therapy has not been adequately effective.
finding may indicate a direct effect of smoking, in which nicotine impacts the appropriate development of the fetus' brain. Another recent study, conducted by Kabir et al. [18 ] , looked at exposure to second-hand smoke postnatally. Using the data from the 2007 National Survey on Children's Health, the study found that children who were exposed to second-hand smoke at home had a 50% higher chance of having two or more childhood behavioral disorders compared with unexposed children. This was especially true for boys and for older children (ages 9-11 years). This study did not, however, distinguish between maternal and paternal smoking or between the number of people in the household who smoked; likewise, no comparison was done between adopted and biologic children. Nevertheless, the findings of these two studies are supported by a multitude of others and indicate that both prenatal and postnatal exposure to smoke is associated with later problems in child behavior [19] .
Associated findings
Preschool children with ADHD often have one or more comorbid conditions, and these comorbid conditions may be associated with greater impairment and a worse outcome [20] . As with school-age children, over 50% of preschool-age children with ADHD are likely to have comorbid behavioral problems [5] . The most common of these include oppositional defiant disorder (ODD) and conduct disorder [21] . These disorders, which comprise the disruptive behavior disorders (DBDs) in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), are characterized by noncompliance and disobedience, and can include more disruptive, dangerous, or aggressive behavior towards authority or peers (DSM-IV). Somewhat surprisingly, in a Swedish study of 3-7-yearold children with ADHD [22] , combined subtypes were twice as likely to have a diagnosis of comorbid ODD as were children with the hyperactive/impulsive subtype. In this study, ADHD did not precede the development of ODD; on the contrary, they developed concomitantly. ODD is clinically significant from a prognostic standpoint. Among preschool children with ODD, the presence of comorbid ADHD is associated with greater impairment in grade school and adolescence. Moreover, the presence of comorbid behavioral disorders in children may be a marker for more severe ADHD symptomatology [8 ] .
In addition to comorbid DBDs, preschool children with ADHD are also more likely to exhibit higher rates of other psychiatric disorders (anxiety and depression), language disorders, developmental delays, and developmental coordination disorders [23, 24, 25 ] . Furthermore, young children diagnosed with ADHD are at increased risk for physical injury, with more visits to the emergency room, accident reports, and unintentional injuries than their peers [26] .
Diagnosis
Currently, the diagnosis of ADHD in preschool-age children is determined in a similar fashion to schoolage children -using the 18 DSM-IV criteria. As discussed, the DSM-IV divides the ADHD diagnosis into three subtypes: predominantly HA/I, predominantly inattentive, and combined types. In order to meet criteria for the HA/I and inattentive subtypes, children must display at least six out of the nine symptoms outlined under each category. Examples of the HA/I symptoms are 'Often fidgets with hands or feet or squirms in seat when sitting still is expected', and 'Often has trouble waiting one's turn,' whereas examples of the inattentive symptoms are 'Often has trouble keeping attention on tasks or play activities', and 'Is often easily distracted'. To be classified as the combined type, children must meet at least six out of the nine criteria in each of the HA/I and inattentiveness categories, for a total of 12 or more symptoms. In addition to these symptoms, children must exhibit clinically significant impairment in two or more settings and the symptoms cannot be better explained by a different mental disorder diagnosis; the impairment requirement applies to all ADHD subtypes.
Many researchers have examined whether the DSM-IV can be accurately and reliably used to identify preschoolage children with ADHD. The DSM-IV has been demonstrated to have concurrent validity. Preschool children diagnosed with ADHD do show impairment in academic and social endeavors. They have been found to have greater problems in friendships and cooperation, and they are more likely to be in special education programs, specifically with significantly lower mathematics achievement [27] . The DSM-IV also has demonstrated predictive validity; children do appear to maintain their diagnoses over time. A study conducted by Lahey et al. [28] found that 75-85% of 4-6-year-old preschool children who met criteria for ADHD still met criteria for ADHD (either the same or another subtype) 3 years later.
Despite the improvement of criteria over time, many have argued that there are nevertheless significant limitations in the diagnostic process, especially for very young children [29] . It is particularly difficult with preschool-age children to distinguish between normal and abnormal levels of hyperactivity, inattention, and impulsiveness; a very wide range of these behaviors could be deemed 'acceptable' [30] . Although, as discussed, the DSM-IV demonstrates concurrent and predictive validity, Chacko et al. [29] have proposed specific changes in diagnostic criteria. They suggest that there should exist a bottom-up, developmentally driven approach to the specification of symptoms, which focuses on the quality of the behaviors rather than the frequency. For example, they believe that children should be evaluated for the quality of their anger as opposed to the frequency of their outbursts. In advocating for diagnostic criteria that are more developmentally appropriate for young children, these authors note that 'Developmental specification of symptoms is likely to substantially enhance accurate identification, thus increasing sensitivity, specificity, and stability of symptoms' ( [29] , p. 637). There is also some debate as to whether the impairment in two settings (namely home and school) that exists in the DSM-IV is appropriate for preschool children [31] . Although many young children do not attend preschool and it may therefore be difficult to obtain 'teacher' ratings, the DSM does require impairment in at least two settings and rating scales may be completed by daycare staff, childcare providers, or outside family members. For parents referred for counseling in behavior management, the American Academy of Pediatrics (AAP) also suggests getting reports from parenting program instructors about the parents and/or child whenever feasible (AAP Guidelines [32] ).
Although the DSM-V has yet to be finalized, the American Psychiatric Association (APA) has released proposed revisions to the diagnostic criteria for ADHD [33] . In its draft revision, the APA elaborates on each symptom already defined in the DSM-IV and adds four additional symptoms for impulsivity. Within the symptom elaborations, efforts have been made to be inclusive of many different age groups ranging from young children to adults. For example, one added symptom of impulsivity states, 'Finds it difficult to resist temptations or opportunities, even if it means taking risks (A child may grab toys off a store shelf or play with dangerous objects; adults may commit to a relationship after only a brief acquaintance or take a job or enter into a business arrangement without doing due diligence)'. The elaboration includes example behaviors for both young children and adults. In addition, the DSM-V addresses the problem of impairment in two or more settings for young children, by suggesting 'friends and relatives' as a potential second observer setting, as opposed to solely school or work. Thus, it is hoped the revised DSM-V may offer solutions to some of the aforementioned problems that exist with operationalizing the current DSM criteria for diagnosing ADHD in young children.
In its newly released guidelines for diagnosis and treatment of ADHD, the AAP continues to endorse use of the DSM criteria and to encourage pediatricians to use rating scales to assist in the diagnosis of ADHD [32] . Certain of these scales, specifically the Conners Parents Rating Scale-Revised, the Conners Teachers Scale-Revised and the AD/HD Rating Scale-IV parent and teacher versions, have demonstrated success with preschoolage children. Although the Vanderbilt parent and teacher rating scales were not constructed for preschool children, they are likely useful for children aged 4 years and above [8 ] . In its revised guidelines, the AAP supports use of the Conners Early Childhood rating scales and the AD/HD Rating Scale-IV for children aged 4 years and older [32] . The Vanderbilt rating scales are available to pediatricians from the AAP through its expanded and revised ADHD Toolkit; the Conners questions are available from the publisher [34] .
Treatment
Parent training in behavior management is generally recommended as the initial treatment strategy for preschool ADHD. This approach is endorsed by the AAP in its newly released treatment guidelines (AAP Guidelines [32] ). Nonetheless, pharmacotherapy may at times be indicated in addition to, or, rarely, in lieu of behavior therapy. Since preschool children with ADHD are at increased risk for a multitude of adverse outcomes, it is important that clinicians not ignore clinical presentation or defer counseling families regarding treatment options.
Behavioral interventions
Parent training has become the mainstay treatment recommended for preschoolers [35] . This kind of intervention is aimed at enhancing and adjusting parenting skills with the aim of improving parent-child relationships. Parents learn to identify the antecedents and alter the consequences of their child's misbehavior. They are also taught to monitor problematic behaviors and to reward positive behaviors appropriately through praise and positive attention. Unwanted behaviors are extinguished through nonphysical punishments, including time-outs [36 ] . Multiple behavior programs exist to assist parents; these include, but are not limited to, the Triple P and the Incredible Years programs. Both of these programs encourage increased one-on-one parent-child interactions and have been shown to successfully reduce disruptive behaviors [37, 38] . Although these programs have been proven efficacious, many parents are reluctant to follow through with recommendations to pursue 'parent training' because they believe that it implies that they are at fault [36 ] . It should be made clear to parents, however, that this is not the case and that parent training has demonstrated greater success than child-focused behavioral interventions.
Many clinicians and the AAP recommend school-based behavioral interventions, even for young children. Although behavior management techniques may be very effective when employed by a teacher with training and experience with these specific approaches, recent data suggest that not all school-based interventions are very effective. A study by Sayal et al. [39 ] found that a schoolbased intervention in which schools were provided with classroom management strategies for handling 4-year-old and 5-year-old children with ADHD was not associated with improved outcomes. Moreover, for the group of young children who were identified as being hyperactive/inattentive but for whom no intervention (teacher education) was provided, higher H/I scores were noted at 5-year follow-up. This study not only raises questions about the efficacy of some school-based interventions but it also highlights the potential risks of early labeling.
Medication
Despite its proven efficacy, parent training in behavior management is not always easy to obtain. First, these programs require a significant amount of time and effort [40 ] . Second, there may not be properly trained professionals available within a reasonable distance from a family's home. Moreover, as many households have health insurance policies that have limited or no mental health coverage, this kind of treatment can be quite costly. Thus, in some cases, families and clinicians may feel compelled to explore treatment with medication.
Until recently, there had been very little systematic research regarding the efficacy of stimulant medication in preschoolers for ADHD. In 2006, a large, prospective multicenter study, known as the Preschool ADHD Treatment Study (PATS), was conducted to examine the effect of methylphenidate (MPH) on young children with ADHD [41] . Interestingly, although the PATS study examined exclusively MPH, short-acting amphetamines are the only medications with a Food and Drug Administration (FDA) indication for treatment of ADHD in children aged 3-5 years. In the PATS study, the medicated children did demonstrate a significant reduction in ADHD symptoms. There are some sensible reasons, however, to hesitate about prescribing medication to children who are so young [42] . In the PATS study, for example, almost one-third of the children exhibited significant side effects, including weight loss, emotional outbursts, anxiety, and insomnia. Eleven percent of the children were actually required to stop taking the medication because of severe side effects. Also, the medicated children in the study were shown to grow about half an inch less in height and weighed about three pounds less than was expected. Because of concerns about tolerability and uncertainties about long-term safety, the AAP does not recommend pharmacotherapy as a first-line treatment for young children with ADHD. (The AAP's revised guidelines do note that, if behavior therapy is unavailable, clinicians may consider the risks of treatment with stimulant medication as a first-line treatment against the potential harm associated with delayed diagnosis and treatment.)
With respect to use of nonstimulant medications in preschool children with ADHD, data from a Michigan database of children on Medicaid revealed that more than 20 different medications were used in this population [43] . This report was rather surprising, especially since so few well designed studies have been conducted with nonstimulant drugs for preschool hyperactivity. One very recent study conducted by Kratochvil et al. [44 ] examined the use of atomoxetine, a nonstimulant agent, in children aged 5 and 6 years. Although atomoxetine was well tolerated, this did not necessarily translate to overall clinical and functional improvement. In other words, although statistically significant improvements in ADHD rating scale scores were noted for the majority of children, the mean final scores were still more than 1 standard deviation (SD) above normal, indicating that clinical symptoms remained. In general, nonstimulant medications should not be considered a first-line treatment approach in which pharmacotherapy is indicated (see Table 1 for formulation-specific information regarding nonstimulant medications).
Although stimulant medications are effective in reducing ADHD symptoms, pediatricians should remain quite cautious about prescribing immediately. There have not been many studies looking at the long-term effects of medicating children at such a young age. The AAP's new recommendations for when to consider pharmacotherapy for a preschool child (aged 4 or 5 years) with ADHD are listed below; this also lists supplemental factors that should be considered when deciding clinically whether or not to prescribe medication.
Clinical indications and considerations for pharmacotherapy for preschoolers with ADHD:
(1) Criteria from new AAP Guidelines for children 4-5 years of age. The risks and benefits of treatment with stimulant medication must be considered for each preschool child with ADHD individually. The AAP notes that 'it is frequently helpful to obtain consultation from a mental health specialist with specific experience with preschool age children if possible'. breakdown' because of the child's behavior. In addition to counseling in behavior management, parents experiencing severe stress and depression or other emotional effects may benefit from supportive counseling and/or other mental health services. (h) Marriage on the verge of divorce or separation because of the child's behavior. In addition to counseling in behavior management, parents experiencing severe stress and depression or other emotional effects may benefit from supportive counseling and/or other mental health services.
The more supplemental criteria that are satisfied, the more comfortable one may feel in recommending pharmacotherapy. However, even when multiple criteria are satisfied, parent training in behavioral treatment management should generally be the first-line approach to treatment. Respite for parents is often an important component as well. For preschool children who are not yet in a preschool but who are suspected of having ADHD, placement in a preschool or Head Start program is very helpful. It not only provides respite for the parent, but it allows trained and experienced educators and/or child care professionals to work with the child. It also provides the child with more appropriate peer models. If a child's behavior does not allow him to enter or remain in a regular daycare setting or preschool program, referral to a special education preschool is warranted.
If a clinician determines that treatment with medication is indicated, it is generally best to start with a very low dose. The AAP treatment guidelines only endorse use of methylphenidate for children 4-5 years old. Although there is indeed a paucity of research with amphetamines in young children, some amphetamine formulations are approved by the FDA for ADHD in children 3 years old and above, and pediatricians may consider prescribing amphetamines in cases in which methylphenidate is not effective or well tolerated. Although dosing and titration guidelines are beyond the scope of this review article, clinicians need to remember that most young children are not able to swallow a pill or capsule. Table 1 summarizes some of the stimulant medication options; it lists specific formulations and modes of administration for young children who cannot swallow pills or capsules. A new website, PillSwallowing.com, is a helpful resource for parents and pediatricians that not only teaches children how to swallow pills and capsules, but also identifies other useful strategies to assist with medication administration.
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Dietary treatment
There has been longstanding debate regarding the relationship between food and hyperactivity. Two recent publications have linked diet and behavior in young children. In 2007, a placebo-controlled study of food coloring by McCann et al. [45] reported an increase in 'hyperactivity'; although this study received considerable media attention, the findings, as reported by the investigators and then by the media, were grossly misleading. This study of normal 3-year-old children noted a very modest increase in activity level (effect size of 0.2) following dietary challenge with food coloring. The investigators did not examine preschool children with ADHD and did not look at hyperactivity as a clinical outcome. Regrettably, the finding of modestly increased activity was mischaracterized by the authors as 'increased hyperactivity.' A more recent study that was also published in the Lancet [46] noted improvement in the behavior of young children with ADHD (aged 4-8) who followed a restricted elimination diet for 5 weeks.
The initial diet consisted of the 'few foods diet' (meat, rice, vegetables, pears, and water) with select additional foods (potatoes, fruit and wheat). If benefit was not noted after 2 weeks, then the diet was gradually further restricted to just the 'few foods diet.' Regrettably, the authors concluded that dietary intervention should be considered in 'all children with ADHD' -even though their study did not include any blinded outcome measure, almost completely excluded children with the predominantly inattentive subtype of ADHD, and did not include any preadolescents or adolescents [47] . Unfortunately, this study also garnered considerable media attention -only further reinforcing public misconceptions regarding the place for dietary treatment for ADHD. Realistically, parents of young children may wish to consider an elimination diet; however, clinicians will need to educate families about the limited data to date regarding its efficacy.
Outcome and prognosis
It has been demonstrated that up to 60% of young children with ADHD do not outgrow their symptoms, making decisions about treatment increasingly important [48] . ADHD diagnoses are often stable from preschool to grade school and even thereafter. Children with ADHD are at increased risk for long-term negative outcomes, including problems in academic achievement and employment attainment [49] . ADHD not only poses considerable challenges to the affected child, but it also greatly affects the child's family -including siblings and the parents' marital functioning. Although few studies have been conducted in preschool-age children, studies examining school-age children have shown that child ADHD predicts maternal depression and that mothers reported greater role dissatisfaction when compared with control mothers [50, 51] .
Another factor that can impact a child's long-term outcome is parental psychopathology, especially ADHD. Songua-Barke et al. [52] demonstrated that maternal ADHD symptoms reduced the effectiveness of parent training programs for preschool children with ADHD. Naturally, the more severe parental symptoms were associated with the greatest reduction in treatment effectiveness. Mothers with ADHD -if they have similar executive function deficits -may have trouble organizing even routine daily activities. Adults with ADHD may likewise have difficulty concentrating and become easily distracted. To the extent that parent training programs require a certain degree of attention and consistency, mothers or fathers with ADHD may not be able to successfully employ these techniques. It is important that pediatricians are vigilant for ADHD in parents of hyperactive preschoolers. If ADHD is suspected in one or both parents, referral to an appropriate 'adult ADHD' resource in the community is warranted since untreated adult 
Conclusion
Although preschool children are, in general, sometimes restless or impulsive due to their young age and relative immaturity, a small number of young children are so restless and impulsive that it interferes with their functioning and may even jeopardize their safety. ADHDeither the predominantly hyperactive-impulsive subtype or the combined subtype -can be reliably diagnosed in preschool children. To satisfy DSM-IV criteria, children must exhibit problematic behavior in two or more settings. Clinicians should not make clinical diagnoses or management decisions based on office observations alone. Rating scales are available to assist with the diagnosis of ADHD and potential comorbid conditions in young children. Evidence-based parent training in behavior management techniques should be the initial treatment strategy. Pharmacotherapy is sometimes indicated as a treatment adjunct or, commonly, a treatment alternative. Recent studies suggest that 'methylphenidate is a moderately effective short-term treatment' ( [2] , p. 361). Key differences between ADHD in preschool versus school-age children are summarized in Table 2 . It is recommended that primary care pediatricians review the AAP's evidence-based guidelines and algorithm for diagnosis and management, since early identification and effective treatment will help ensure optimal outcome for young children with ADHD [32] .
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